LKT Labs, 1143532-39-1

1 - 1 of 1
Sort
View
Show
  • LKT Labs

    AZD-5363 is an oral pan-AKT inhibitor that causes hyperphosphorylation of AKT, locking it in a catalytically inactive state, unable to phosphorylate downstream signaling substrates such as PRAS40 and GSK-ß. This compound displays anticancer chemotherapeutic activity, inhibiting proliferation and…